Your browser doesn't support javascript.
loading
A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System.
Beresniak, Ariel; Russo, Michele; Forte, Gianpiero; Laganà, Antonio Simone; Oliva, Mario Montanino; Aragona, Cesare; Chiantera, Vito; Unfer, Vittorio.
Affiliation
  • Beresniak A; Data Mining International SA, Geneva, Switzerland.
  • Russo M; R&D Department, Lo.Li. Pharma, 00156, Rome, Italy.
  • Forte G; R&D Department, Lo.Li. Pharma, 00156, Rome, Italy.
  • Laganà AS; The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00161, Rome, Italy.
  • Oliva MM; Unit of Obstetrics and Gynecology, "Paolo Giaccone" Hospital, 90127, Palermo, Italy.
  • Aragona C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127, Palermo, Italy.
  • Chiantera V; The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00161, Rome, Italy.
  • Unfer V; Department of Obstetrics and Gynecology, Santo Spirito Hospital, 00193, Rome, Italy.
Sci Rep ; 13(1): 17789, 2023 10 18.
Article in En | MEDLINE | ID: mdl-37853019
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polycystic Ovary Syndrome Language: En Journal: Sci Rep Year: 2023 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polycystic Ovary Syndrome Language: En Journal: Sci Rep Year: 2023 Type: Article Affiliation country: Switzerland